These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36959058)

  • 1. Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinoma.
    Davaro F; Davaro E; Rose K; Murthy P; Huelster H; Naidu S; Camperlengo L; Grass GD; Vosoughi A; Chumbalkar V; Jain RK; Zemp L; Yu A; Poch MA; Spiess PE; Gilbert SM; Sexton WJ; Li R
    Urol Oncol; 2023 Sep; 41(9):389.e7-389.e13. PubMed ID: 36959058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
    Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
    Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template.
    Fransen van de Putte EE; Hermans TJ; Werkhoven Ev; Mertens LS; Meijer RP; Bex A; Wassenaar AE; van der Poel HG; van Rhijn BW; Horenblas S
    Urol Oncol; 2015 Dec; 33(12):504.e19-24. PubMed ID: 26329817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection.
    Morton E; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim SP; Bellmunt J; Kaplan I; Olumi AF; Gershman B
    Urol Oncol; 2023 May; 41(5):255.e7-255.e14. PubMed ID: 36470805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care.
    Hermans TJ; Fransen van de Putte EE; Fossion LM; Werkhoven EV; Verhoeven RH; van Rhijn BW; Horenblas S
    Urol Oncol; 2016 Dec; 34(12):532.e7-532.e12. PubMed ID: 27491835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
    Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
    World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
    Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N
    Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer.
    Sodagum L; Passarelli R; Pfail J; Patel HV; Chua K; Doppalapudi SK; Golombos D; Elsamra SE; Singer EA; Jang TL; Srivastava A; Ghodoussipour S
    Urol Oncol; 2024 Jan; 42(1):21.e9-21.e20. PubMed ID: 37953186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.
    Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S
    Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
    Kosiba M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2022 Apr; 20(2):195.e1-195.e8. PubMed ID: 34906434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.
    Tarin TV; Power NE; Ehdaie B; Sfakianos JP; Silberstein JL; Savage CJ; Sjoberg D; Dalbagni G; Bochner BH
    Eur Urol; 2012 May; 61(5):1025-30. PubMed ID: 22342773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
    Necchi A; Mariani L; Lo Vullo S; Yu EY; Woods ME; Wong YN; Harshman LC; Alva A; Sternberg CN; Bamias A; Grivas P; Koshkin VS; Roghmann F; Dobruch J; Eigl BJ; Nappi L; Milowsky MI; Niegisch G; Pal SK; De Giorgi U; Recine F; Vaishampayan U; Berthold DD; Bowles DW; Baniel J; Theodore C; Ladoire S; Srinivas S; Agarwal N; Crabb S; Sridhar S; Golshayan AR; Ohlmann C; Xylinas E; Powles T; Rosenberg JE; Bellmunt J; van Rhijn B; Galsky MD; Hendricksen K;
    Eur Urol Focus; 2019 Mar; 5(2):242-249. PubMed ID: 28753897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer.
    von Deimling M; Furrer M; Mertens LS; Mari A; van Ginkel N; Bacchiani M; Maas M; Pichler R; Li R; Moschini M; Bianchi A; Vetterlein MW; Lonati C; Crocetto F; Taylor J; Tully KH; Afferi L; Soria F; Del Giudice F; Longoni M; Laukhtina E; Antonelli A; Rink M; Fisch M; Lotan Y; Spiess PE; Black PC; Kiss B; Pradere B; Shariat SF;
    BJU Int; 2024 Mar; 133(3):341-350. PubMed ID: 37904652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
    Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
    JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of Lymph Node Outcomes in Partial Cystectomy for Muscle-Invasive Urothelial Carcinoma of the Bladder.
    Klose C; Gordon O; Sparks A; Whalen M
    Clin Genitourin Cancer; 2023 Dec; 21(6):703-709. PubMed ID: 37336704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
    Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ
    Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Lymph Node Dissection in Patients With Muscle-Invasive Bladder Cancer Who Underwent Radical Cystectomy Following Neoadjuvant Chemotherapy.
    Zennami K; Takahara K; Nukaya T; Takenaka M; Ichino M; Sasaki H; Kusaka M; Sumitomo M; Shiroki R
    Clin Genitourin Cancer; 2024 Apr; 22(2):1-9. PubMed ID: 37423863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.